Articles related to MEDICAL UNIVERSITY PRESS

Under Dr. Laurie Glimcher’s leadership, Dana-Farber Cancer Institute is embarking on a transformative journey with the creation of a new, dedicated cancer hospital, promising a future of specialized care and improved patient experiences in oncology.

Explore the transformative potential of antibody-drug conjugates (ADCs) in cancer therapy, offering targeted treatments with reduced side effects. Recent approvals and ongoing trials signify a significant shift towards precision medicine in oncology.

Explore the potential of IS-002, an imaging agent that offers a new dimension in intraoperative prostate cancer detection, promising a more targeted approach to surgical intervention and patient management.

In a significant advance for pediatric diabetes care, the introduction of the AI-based IDx-DR has doubled screening rates for diabetic retinopathy, underscoring the potential of technology to democratize healthcare access and eliminate racial bias in diagnostic processes.

Leveraging artificial intelligence, the CathEF algorithm offers a groundbreaking method to assess heart function directly from angiogram videos, potentially reducing the need for invasive diagnostics and enhancing patient care strategies.

Johns Hopkins’ cardiac surgery team’s strategic expansion brings together globally recognized experts, enhancing our capabilities in treating complex heart conditions and advancing research in heart and lung transplantation.